Seeking Alpha

VivoSim Presents Best-in-Class Liver Toxicology Prediction Results at Digestive Disease Week Conference

SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (VIVS) (the “Company”) announced today that its world-leading NAMkind™ platform for liver toxicology prediction, provided as a commercial ...
ascopubs.org

Self-Supervised Transformer-Based Pipeline for Liver Tumor Segmentation and Type Classification

First, we pretrained the encoder of a transformer-based network using a self-supervised approach on unlabeled abdominal computed tomography images. Subsequently, we fine-tuned the segmentation network ...
News Medical

Detecting hepatotoxic drugs with human liver microtissues

This article is based on a poster originally authored by L. Fäs, F. Wenz, M. Tu, K. Sanchez, N. Zapiórkowska-Blumer, H. Varga and K. Kaczmarska, which was presented at ELRIG Drug Discovery 2024 in ...
Morningstar

GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)

Affecting up to 5% of the global population, SLD represents an area of significant unmet medical need with limited treatment options Phase II data show potential of efimosfermin to reverse liver ...